Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. 勃林格殷格翰是一家拥有130年历史，在世界上首屈一指的制药公司
http://www.boehringer-ingelheim.cn/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
3.6 seconds
16x16
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
39
SITE IP
120.136.171.68
LOAD TIME
3.614 sec
SCORE
6.2
Boehringer Ingelheim 勃林格殷格翰 - 创新创造价值 | boehringer-ingelheim.cn Reviews
https://boehringer-ingelheim.cn
Boehringer Ingelheim is one of the world's leading research-driven pharmaceutical companies with 130 years of experience. 勃林格殷格翰是一家拥有130年历史，在世界上首屈一指的制药公司
boehringer-ingelheim.cn
勃林格殷格翰宣传片
http://www.boehringer-ingelheim.cn/corporate_profile/BICNvideo.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
新闻中心
http://www.boehringer-ingelheim.cn/news_centre.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
制造运营
http://www.boehringer-ingelheim.cn/Factory_lab.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
生物制药
http://www.boehringer-ingelheim.cn/SWZY.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation. 生产基地可进行多品种，各种规模的 cGMP 生产，得到主要权威机构 例如 美国食品和药物管理局 (FDA)、欧洲药品管理局 (EMA) 以及日本厚生劳动省 (MHLW) 的认证批准。 由 EMA、FDA 和 MHLW 许可的大规模 GMP 生产设施. 勃林格殷格翰BioXcellence特别推出针对单克隆抗体的 精益临床申请 方案，该方案由基于平台技术和标准化流程的简化工作包构成，可以大大加快细胞系的开发、第 I 阶段工艺开发以及临床前和临床用品的开发。 在这个经济高效的方案中，用于毒理学实验的原料药以及用于临床研究的产成药品从开发起计算，分别可在 13 个月和 16 个月内完成交付。 勃林格殷格翰BioXcellence组建了一支成熟的商务拓展大客户管理 (BD and KAM) 团队，在美洲、欧洲和亚太地区等主要市场发挥作用。 我们的 BD and KAM 团队渴望与您共同探讨需求，及时满足您的一切请求。
自主保健品
http://www.boehringer-ingelheim.cn/products/consumer_healthcare.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
TOTAL PAGES IN THIS WEBSITE
20
勃林格殷格翰和礼来2型糖尿病新复方制剂 获欧洲上市推荐
http://www.boehringer-ingelheim.com.cn/news_centre/press_releases/2015040202.html
勃林格殷格翰中国 2016.08.15. Jump to main navigation. Jump to meta navigation. 勃林格殷格翰 BI 和礼来公司 Lilly 今日宣布，他们已从欧洲药品管理局(EMA)人用药品管理委员会 CHMP 收到积极意见，建议批准将恩格列净 empagliflozin /盐酸二甲双胍单片复方制剂用于2型糖尿病(T2D)的治疗。 恩格列净/盐酸二甲双胍单片复方制剂含钠-葡萄糖协同转运蛋白2 SGLT2 抑制剂恩格列净 Jardiance.
制造运营
http://www.boehringer-ingelheim.com.cn/Factory_lab.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
公司概述
http://www.boehringer-ingelheim.com.cn/corporate_profile.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
企业社会责任
http://www.boehringer-ingelheim.com.cn/corporateresponsibility0.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
加入我们
http://www.boehringer-ingelheim.com.cn/careers.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation. 加入勃林格殷格翰 中国 ，不只是找到一份工作，它是你事业和实现自我，成就卓越的机遇与起点 在勃林格殷格翰，人才不拘一格，职业途径多样，发展机会无穷 每一个勃林格殷格翰人都高度认同公司的价值观 相互尊重，信任，同理心和热情 并时刻践行着 创新展现价值 的准则，共同努力为提高人类的整体健康生活水平而做出贡献，也使勃林格殷格翰公司成为行业的最佳雇主.
我们的产品
http://www.boehringer-ingelheim.com.cn/products.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
新药上市推动勃林格殷格翰未来增长
http://www.boehringer-ingelheim.com.cn/news_centre/press_releases/20150422.html
勃林格殷格翰中国 2016.08.15. Jump to main navigation. Jump to meta navigation. 据悉，2014年公司净销售额约为133亿欧元，经汇率调整后，下降3.2 以欧元计算为-5.3。 产品家族净销售额经汇率校正后增长约37%，达到6.36亿欧元 以欧元计算 34.2。 动物保健业务方面，勃林格殷格翰2014年再次实现超过10亿欧元的净销售额，这相当于集团净销售总额的8 , 汇率校正后的增长率为6.8% 以欧元计为5.6% ，超过市场平均水平。 小动物业务的净销售额汇率校正后增长率为18.1% (以欧元计为17.2%) , 是主要的增长推动者。 其净销售额经汇率校正后增加33.1 以欧元计为 32.3 ，达到6900万欧元。 最近几个月上市的新药包括治疗慢阻肺的STRIVERDI 能倍乐 用于治疗2型糖尿病的JARDIANCE 和活性成分为利格列汀与恩格列净组合的GLYXAMBI 治疗特发性肺纤维化 IPF 的OFEV 以及2015年1月初上市的用于化疗后晚期肺腺癌患者治疗的VARGATEF。
Sitemap
http://www.boehringer-ingelheim.com.cn/sitemap.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
亚洲首个“2型糖尿病早期对话报告”发布 “医患轻松”成重要课题
http://www.boehringer-ingelheim.com.cn/news_centre/press_releases/_2_.html
勃林格殷格翰中国 2016.08.15. Jump to main navigation. Jump to meta navigation. 亚洲首个 2型糖尿病早期对话报告 发布 医患轻松 成重要课题. 2015年4月17日 北京 今天公布的亚洲首个 2型糖尿病早期对话报告 显示，医患的早期对话确定了2型糖尿病患者未来治疗的基调，同时将影响到2型糖尿病患者能否持续有效治疗疾病并降低发生糖尿病并发症的风险。
勃林格殷格翰宣传片
http://www.boehringer-ingelheim.com.cn/corporate_profile/BICNvideo.html
勃林格殷格翰中国 2016.08.12. Jump to main navigation. Jump to meta navigation.
TOTAL LINKS TO THIS WEBSITE
39
boehringer-ingelheim-venture.com
Home
Boehringer Ingelheim Venture Fund. Boehringer Ingelheim Venture Fund. 55216 Ingelheim am Rhein. Phone 49 6132 77 8740.
Homepage | boehringer-ingelheim.at
Skip to main content. Audit Beruf und Familie. Erkrankungen des Zentralen Nervensystems. Institut für Molekulare Pathologie. Werte schaffen durch Innovation. Boehringer Ingelheim ist ein weltweit tätiges, forschendes Pharmaunternehmen, bei dem Menschen aus vielen verschiedenen Kulturen zusammenarbeiten. Anschauen the video on Unsere Vision. Worauf wir uns konzentrieren. Mehr on Worauf wir uns konzentrieren. Integriertes Kompetenzzentrum für Arzneimittelforschung in der Onkologie. 500 neue Jobs LSCC.
Boehringer Ingelheim - La valeur par l’innovation
Skip to main content. Nous améliorons la santé avec passion. Boehringer Ingelheim est une société pharmaceutique mondiale axée sur la recherche englobant de nombreuses cultures et diverses communautés. Les objectifs et convictions du groupe d’entreprises Boehringer Ingelheim peuvent être résumés en quelques mots : La valeur par l’innovation, le concept central de notre vision d’entreprise. Visionner the video on Notre vision. Notre approche de la découverte. Lire plus on Notre approche de la découverte.
Boehringer Ingelheim - Value Through Innovation
Skip to main content. Research and development sites. Burlington - Head Office. We passionately improve health. Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. Animal Health: One business, one vision, one global leader in disease prevention and treatment. Boehr...
Homepage | boehringer-ingelheim.ch
Skip to main content. Werte - Vertrauen durch Transparenz. Herzlich Willkommen bei Boehringer Ingelheim Schweiz. Wir schaffen Werte durch Innovation! Werte - Vertrauen durch Transparenz.
Boehringer Ingelheim 勃林格殷格翰 - 创新创造价值
Skip to main content. PRESS RELEASE 18 十二月 2017 - 14:02. PRESS RELEASE 02 八月 2017 - 11:37.
Boehringer Ingelheim - Value Through Innovation
Skip to main content. Image and Video Mediapool. Select your area of interest / professional background. Health Care Professional in the US. Health Care Professional outside the US. We passionately improve health. Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. Careers in the UK. We will improve the health and wellbeing of people and animals through being part of an independent, innovative, research and development driven company.
Boehringer Ingelheim - Value Through Innovation
Skip to main content. Boehringer Ingelheim Venture Fund. Select your area of interest / professional background. Health Care Professional in the US. Health Care Professional outside the US. We passionately improve health. Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. Today, as a research-driven pharmaceutical company we focus more than ever on a variety of partnerships. Read more in our Annual Report 2016. Scientists at Boehringer ...
Boehringer Ingelheim - Value Through Innovation
Skip to main content. Our Vision and Values. Our commitment to Patients. Research and Development Sites. Working with Healthcare Professionals. We passionately improve health. Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. What We Focus On. Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need. Read more on What We Focus On.
Nosso negócio | Boehringer Ingelheim
Skip to main content. Imunologia e sistema respiratório. Doença pulmonar obstrutiva crônica (DPOC). Fibrose pulmonar idiopática (FPI). A missão da Boehringer Ingelheim é encontrar soluções terapêuticas inovadoras e acessíveis à população de forma sustentável. Conheça um pouco da história, a atuação e o local em que são produzidos os medicamentos exportados para dezenas de países. Press release 15 Fev 2018 - 14:00. Um negócio, uma visão, uma liderança global na prevenção e no tratamento de doenças. O nome...
Welcome to WeChat Backend | WeChat Backend
Skip to main content. Welcome to WeChat Backend. No front page content has been created yet.
